Live from the NIH registry
Studies recruiting near Ogden right now
Top 25 of 114 recruiting studies, sorted by proximity — each links to its official registry page
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
McKay-Dee Hospital Center — Ogden, Utah (0.4 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Adaptation and Pilot Implementation of ePNa Clinical Decision Support for Utah Urgent Care Clinics
Pneumonia
N/A
Interventional 4,000 participants sought
South Ogden Instacare — South Ogden, Utah (2.5 mi)
· Sponsor: Intermountain Health Care, Inc.
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
Type 2 Diabetes Mellitus, Type 2 Diabetes With Chronic Kidney Disease
Phase 3
Interventional 900 participants sought
Research Site — Ogden, Utah (0.4 mi)
· Sponsor: AstraZeneca
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
Locally Advanced Cervical Adenocarcinoma, Locally Advanced Cervical Adenosquamous Carcinoma
Phase 3
Interventional 336 participants sought
Farmington Health Center — Farmington, Utah (17.6 mi)
· Sponsor: National Cancer Institute (NCI)
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Metabolic Dysfunction-Associated Steatotic Liver Disease
Phase 3
Interventional 4,500 participants sought
Care Access - Ogden — Ogden, Utah (0.4 mi)
· Sponsor: Eli Lilly and Company
A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata
Alopecia Areata
Phase 3
Interventional 1,330 participants sought
AMR Clinical — Layton, Utah (11.6 mi)
· Sponsor: Pfizer
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Adenocarcinoma
Phase 3
Interventional 1,260 participants sought
McKay-Dee Hospital Center — Ogden, Utah (0.4 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis
Ulcerative Colitis
Phase 2
Interventional 99 participants sought
Investigational Site Number: 8400007 — Ogden, Utah (0.4 mi)
· Sponsor: Sanofi
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
COPD (Chronic Obstructive Pulmonary Disease)
Phase 3
Interventional 5,000 participants sought
Research Site — Ogden, Utah (0.4 mi)
· Sponsor: AstraZeneca
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne
Acne
Phase 1, Phase 2
Interventional 800 participants sought
Alpine Research Association- Site Number : 8400050 — Layton, Utah (11.6 mi)
· Sponsor: Sanofi Pasteur, a Sanofi Company
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes
Diabetes Mellitus, Type 1
Phase 3
Interventional 150 participants sought
Advanced Research Institute - Ogden — Ogden, Utah (0.4 mi)
· Sponsor: vTv Therapeutics
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
High Risk Cardiovascular Disease, Hypertension
Phase 3
Interventional 11,000 participants sought
Clinical Trial Site — Layton, Utah (11.6 mi)
· Sponsor: Alnylam Pharmaceuticals
IC-8 Apthera IOL New Enrollment Post Approval Study
Cataract, Presbyopia
N/A
Observational 435 participants sought
Utah Eye Centers — Bountiful, Utah (23.8 mi)
· Sponsor: Bausch & Lomb Incorporated
A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-159642 in Participants With Advanced Solid Tumors
Advanced Solid Tumors
Phase 1
Interventional 220 participants sought
START Mountain — Ogden, Utah (0.4 mi)
· Sponsor: Vividion Therapeutics, Inc.
Combination Antibiotic Therapy for Staphylococcus Aureus Bacteremia
Staphylococcus Aureus Bacteremia
Phase 4
Interventional 2,096 participants sought
McKay-Dee Hospital — Ogden, Utah (0.4 mi)
· Sponsor: Intermountain Health Care, Inc.
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
Type 2 Diabetes Mellitus
Phase 3
Interventional 1,200 participants sought
Research Site — Bountiful, Utah (23.8 mi)
· Sponsor: AstraZeneca
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
Alzheimer's Disease
Phase 3
Interventional 426 participants sought
Local Institution - 2612 — Bountiful, Utah (23.8 mi)
· Sponsor: Bristol-Myers Squibb
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
B Acute Lymphoblastic Leukemia
Phase 3
Interventional 303 participants sought
McKay-Dee Hospital Center — Ogden, Utah (0.4 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
Chronic Migraine
Phase 3
Interventional 420 participants sought
Alpine Research Organization - Clinton /ID# 276527 — Clinton, Utah (7.4 mi)
· Sponsor: AbbVie
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
Head and Neck Squamous Cell Carcinoma, Stage I Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8
Phase 3
Interventional 228 participants sought
Farmington Health Center — Farmington, Utah (17.6 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease
Graves Disease
Phase 3
Interventional 300 participants sought
Site-013 — Layton, Utah (11.6 mi)
· Sponsor: Biohaven Therapeutics Ltd.
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
COVID-19 SARS-CoV-2 Infection
Phase 3
Interventional 2,330 participants sought
Alpine Research Organization — Clinton, Utah (7.4 mi)
· Sponsor: Pfizer
Lot-to-lot Consistency Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From 2 Months of Age
Pneumococcal Immunization, Healthy Volunteers
Phase 3
Interventional 2,195 participants sought
Rio Clinical Trials - Canyon View- Site Number : 8400031 — Ogden, Utah (0.4 mi)
· Sponsor: Sanofi
An Exploratory Efficacy and Safety Study of DFL24498 Topical Ophthalmic Solution Compared With Vehicle in Participants With Dry Eye Disease
Dry Eye Disease (DED)
Phase 2
Interventional 417 participants sought
Alpine Research Organization, Inc. — Clinton, Utah (7.4 mi)
· Sponsor: Dompé Farmaceutici S.p.A
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
Phase 3
Interventional 1,350 participants sought
89bio Clinical Study Site — Ogden, Utah (0.4 mi)
· Sponsor: 89bio, Inc.